We are live on ! Find out more
RVMD icon

Revolution Medicines
RVMD

688 hedge funds and large institutions have $40.1B invested in Revolution Medicines in 2026 Q2 according to their latest regulatory filings, with 243 funds opening new positions, 236 increasing their positions, 150 reducing their positions, and 62 closing their positions.

New
Increased
Maintained
Reduced
Closed

292% more first-time investments, than exits

New positions opened: 243 | Existing positions closed: 62

110% more capital invested

Capital invested by funds: $19.1B → $40.1B (+$21B)

89% more call options, than puts

Call options by funds: $741M | Put options by funds: $391M

57% more repeat investments, than reductions

Existing positions increased: 236 | Existing positions reduced: 150

34% more funds holding

Funds holding: 513 → 688 (+175)

2% more funds holding in top 10

Funds holding in top 10: 46 → 47 (+1)

0.43% more ownership

Funds ownership: 100.05% → 100.49% (+0.43%)

Holders
688
Holders Change
+175
Holders Change %
+34.11%
% of All Funds
8.31%
Holding in Top 10
47
Holding in Top 10 Change
+1
Holding in Top 10 Change %
+2.17%
% of All Funds
0.57%
New
243
Increased
236
Reduced
150
Closed
62
Calls
$741M
Puts
$391M
Net Calls
+$350M
Net Calls Change
+$537M

Top Buyers

Rank Fund Capital Flow
1
DGM
Darwin Global Management
Jersey
+$1.23B
2
Capital World Investors
Capital World Investors
California
+$585M
3
Fidelity Investments
Fidelity Investments
Massachusetts
+$546M
4
JP Morgan Chase
JP Morgan Chase
New York
+$438M
5
BlackRock
BlackRock
New York
+$363M

Top Sellers

Rank Fund Capital Flow
1
Adage Capital Partners
Adage Capital Partners
Massachusetts
-$713M
2
Wellington Management Group
Wellington Management Group
Massachusetts
-$319M
3
VPC
Vestal Point Capital
New York
-$281M
4
ADIC
Abu Dhabi Investment Council
United Arab Emirates
-$234M
5
LGM
Logos Global Management
California
-$190M
Name Holding Trade Value Shares
Change 		Change in
Stake
PWA
626
Physician Wealth Advisors
Utah
$6.93K +$3.65K +25 +208%
HC
627
Hurley Capital
New York
$6.93K +$5.41K +37 New
TM
628
Torren Management
California
$6.55K – – –
GSWM
629
Golden State Wealth Management
California
$6.55K +$5.11K +35 New
AFC
630
Ares Financial Consulting
California
$6.37K +$4.97K +34 New
TFM
631
TFC Financial Management
Massachusetts
$6.37K +$4.97K +34 New
FC
632
Financial Consulate
Maryland
$5.99K +$2.48K +17 +113%
CFO
633
CVA Family Office
Colorado
$5.99K +$4.67K +32 New
IAS
634
IMA Advisory Services
Colorado
$5.81K +$2.04K +14 +82%
S
635
Sachetta
Massachusetts
$5.06K +$3.94K +27 New
MNA
636
Manning & Napier Advisors
New York
$5.01K +$3.8K +26 New
O
637
Ossiam
France
$4.5K +$3.51K +24 New
AA
638
Ancora Advisors
Ohio
$3.75K -$36.2K -248 -93%
MAM
639
Marquette Asset Management
Minnesota
$3.75K – – –
EI
640
EFG International
$3.56K +$2.77K +19 New
CA
641
Continuum Advisory
Idaho
$3.18K +$2.48K +17 New
RWM
642
RMG Wealth Management
Wisconsin
$3.08K +$2.19K +15 New
RWM
643
Rialto Wealth Management
New York
$3K +$1.31K +9 +129%
EWP
644
Elevation Wealth Partners
California
$2.81K +$2.19K +15 New
BIM
645
Breakwater Investment Management
Washington
$2.44K – – –
CFD
646
Creative Financial Designs
Indiana
$2.44K – – –
NB
647
NBT Bank
New York
$2.44K – – –
MCM
648
MV Capital Management
Maryland
$2.06K +$1.46K +10 +1,000%
HFS
649
Hughes Financial Services
Virginia
$2.06K +$1.31K +9 +450%
AEPWM
650
Atlantic Edge Private Wealth Management
Florida
$1.87K +$1.46K +10 New
24 25
26
27 28

RVMD Hedge Fund Activity: Q2 2026 in Review

688 of the 8,279 institutional investors tracked by Wall St. Rank reported a position in Revolution Medicines (RVMD) for Q2 2026, worth a combined $40.1B — up 110% from $19.1B a quarter earlier.

Buyers outnumbered sellers: 243 funds opened new RVMD positions and 62 closed out — a net gain of 181 holders — while 236 added to existing stakes and 150 trimmed.

The largest buyer was Darwin Global Management, adding an estimated $1.23B. The largest seller was Adage Capital Partners, cutting an estimated $713M.

  • 688 institutional investors held Revolution Medicines (RVMD) as of Q2 2026, up from 513 in Q1 2026.
  • Funds reported $40.1B of Revolution Medicines stock for Q2 2026, up 110% quarter-over-quarter.
  • 243 funds opened new Revolution Medicines positions in Q2 2026 and 62 closed out, a net change of +181 holders.
  • The largest Revolution Medicines buyer in Q2 2026 was Darwin Global Management, an estimated $1.23B added.
  • The largest Revolution Medicines seller in Q2 2026 was Adage Capital Partners, an estimated $713M sold.

Based on aggregated 13F filings for Q2 2026.